AM-CATH21

General Information


DRACP ID  DRACP00666

Peptide Name   AM-CATH21

Sequence  GLFKKLRRKIKKGFKKIFKRL

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma Not active up to 100 µg/ml MTT assay 24h 1

Hemolytic Activity  Sheep erythrocytes(Not active up to 300 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00666

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C127H222N38O22

Absent amino acids  ACDEHMNPQSTVWY

Common amino acids  K

Mass  299031

Pl  12.85

Basic residues  11

Acidic residues  0

Hydrophobic residues  8

Net charge  11

Boman Index  -5374

Hydrophobicity  -79.52

Aliphatic Index  92.86

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28089718

Title  Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae

Doi 10.1016/j.dci.2017.01.011

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.